In early August, Novo Nordisk announced that Wegovy reduces the risk of heart attack, stroke or heart-related death in people with cardiovascular disease and obesity by 20%, a result expected to boost use of the medicine even further
If this pattern is bothersome or significantly impacts your eating habits, discuss it with your provider
Why Choose Aesthetic + Mind MD for Semaglutide & Tirzepatide (GLP-1 Injections) in Wellesley, MA
Its time to take control of your weight, health, and confidence for a new and improved you, so what are you waiting for?
Its not a magic bullet that makes you skinny overnight, but its a consistent, measurable change
It sounds a cautionary note for short-term use without a more comprehensive approach to weight management. Overeating far more likely Adam Collins, associate professor of nutrition at the University of Surrey in England, who was not involved in the study, called the paper timely and important. Collins underlined that weight regain is a common issue in all weight loss interventions, but the paper shows that this problem is amplified with GLP-1 medications
